David M. Habiel
- Immunology top 10%
- Phagocytosis and Immune Regulation 4
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 19
- Neonatal Respiratory Health Research 5
- Medical Imaging and Pathology Studies 3
- Clinical Biochemistry top 5%
- Cancer Research top 10%
-
- Occupational exposure and asthma 4
-
- Extracellular vesicles in disease 3
-
- Cancer Immunotherapy and Biomarkers 3
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 3
- Co-authors
- Cory M. HogaboamAna Lúcia CoelhoRichard R. KewM. HohmannWaldiceu A. VerriMilena S. EspíndolaKenneth B. MarcuMarianna Penzo
- Partner nations
- United StatesAustraliaItaly
In The Last Decade
David M. Habiel
40 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 100
- Immunology 416
- Pulmonary and Respiratory Medicine 611
- Clinical Biochemistry 100
- Cancer Research 190
- Physiology 182
Countries citing papers authored by David M. Habiel
This map shows the geographic impact of David M. Habiel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Habiel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Habiel more than expected).
Fields of papers citing papers by David M. Habiel
This network shows the impact of papers produced by David M. Habiel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Habiel. The network helps show where David M. Habiel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David M. Habiel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2023 | 12 | |
| 3 | 2020 | 38 | |
| 4 | 2019 | 5 | |
| 5 | 2019 | 90 | |
| 6 | 2019 | 69 | |
| 7 | 2019 | 12 | |
| 8 | 2018 | 22 | |
| 9 | 2018 | 41 | |
| 10 | 2018 | 9 | |
| 11 | 2018 | 68 | |
| 12 | 2018 | 158 | |
| 13 | 2018 | 33 | |
| 14 | 2017 | 28 | |
| 15 | 2017 | 26 | |
| 16 | 2014 | 21 | |
| 17 | 2013 | 31 | |
| 18 | 2013 | 30 | |
| 19 | 2011 | 17 | |
| 20 | 2010 | 3 |
About David M. Habiel
David M. Habiel is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 41 papers that have together received 1.6k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (19 papers), Neonatal Respiratory Health Research (5 papers), Occupational exposure and asthma (4 papers), Phagocytosis and Immune Regulation (4 papers), Medical Imaging and Pathology Studies (3 papers), Extracellular vesicles in disease (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). The work is most often cited by research in Immunology (416 citations), Pulmonary and Respiratory Medicine (611 citations) and Clinical Biochemistry (100 citations). David M. Habiel has collaborated with scholars based in United States, Australia and Italy. Frequent co-authors include Cory M. Hogaboam, Ana Lúcia Coelho, Richard R. Kew, M. Hohmann, Waldiceu A. Verri, Milena S. Espíndola, Kenneth B. Marcu, Marianna Penzo, Edward A. Fisher and Dianhua Jiang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.